Boson Ventures × WuXi AppTec · Monday 19 October 2026
Australia–China BioInnovation Roundtable 2026
Going Global, Together
In partnership with
Principal partner, partner, and official recognition
Principal Partner
Partner
Official Satellite Event
The Australia–China BioInnovation Roundtable is an official satellite event of AusBiotech's Australia's Biggest Week in Biotech.
Learn more about Australia's Biggest Week in Biotech →About the Roundtable
A bilateral bridge between Australia and China's biotech ecosystems
Now in its third year, the Roundtable brings senior biotech and pharma leaders, investors, and policymakers from Australia and China into the same room — not a trade-show crowd, but a working session built for real partnerships to start.
100+
Delegates across Melbourne and Shanghai in 2025
43,000+
Online audience reached in 2025
Programme
12:30 – 6:30 PM, Monday 19 October 2026 (Gold Coast)
Further speakers to be announced shortly. Programme subject to minor change.
12:30 PM
Registration and light lunch
Registration ahead of the opening session, with a light lunch.
1:00 PM
Welcome and opening remarks
Alan Cui, Managing Partner, Boson Ventures · Dr Zhou Zhou, Head of Asia-Pacific Sales & Marketing in Testing, WuXi AppTec · with invited guests
1:15 PM
Scene-setter: the Australian ecosystem
Where Australian biotech stands in 2026, and the challenges it faces. Stu Dignam, CEO, AUScelerate.
1:35 PM
The China perspective
The Chinese ecosystem and a first-hand account of how it has developed.
1:55 PM
Panel: Collaboration Beyond Borders
How each ecosystem's push to go global is reshaping the way it operates, and where the two paths cross. Moderated discussion, then open floor.
2:55 PM
Afternoon tea
Refreshments and informal networking.
3:20 PM
Spotlight and technical clinic
A keynote from Dr Yi Jin, Vice President and Chief Toxicologist at WuXi AppTec, then cross-border development in practice — including how the R&D tax incentive works when you engage an offshore partner, answered by an Australian tax specialist and a company that has done it.
4:00 PM
Investor panel
The capital view from both markets.
4:50 PM
Roundtable: capital, partnering and going global
Facilitated, no stage. What makes a cross-border partnership work, and what makes one fail.
5:20 PM
Closing remarks
Reflections on the day and what's next for the corridor.
5:30 PM
Networking drinks & reception
Runs through to 6:30 PM.
Speakers
Confirmed speakers
Alan Cui
Managing Partner, Boson Ventures
Stuart Dignam
CEO · AUScelerate
Dr Yi Jin
Vice President, Chief Scientific Toxicologist · WuXi AppTec
Christina Lian
Director of Business Development · WuXi AppTec
Dr Ben Phillis
Head of Investment Fund · UniQuest
Ru Tao
Managing Director – Biotech · Shanghai Guotou Xiandao Fund
Dr Zhou Zhou
Head of Asia-Pacific Sales & Marketing in Testing · WuXi AppTec
Who attends
Built for the people making Australia–China biotech deals happen
Biotech & pharma leaders
Founders, CEOs, CSOs and heads of development from pre-clinical through Phase II, plus R&D and partnering teams from Australian pharma.
Investors & fund managers
Life sciences investors, family offices, and cross-border funds active in Australia–China.
Research & ecosystem leaders
Translational research leaders, institute directors, and commercialisation offices, alongside R&D tax and IP advisers, CROs and clinical trial networks.
Delegates from China
Chinese biotech and pharmaceutical delegates attending Australia's Biggest Week in Biotech.
Registration
Secure your seat — capacity is capped
AUD $29
Early bird · until 30 September 2026
AUD $59
Standard · from 1 October 2026
Invited guests: use the promo code in your invitation at checkout.
Join us on the Gold Coast — or virtually from Shanghai.
AusBiotech's Australia's Biggest Week in Biotech brings together the biotechnology and life sciences community for a week of sector events, collaboration and connection on the Gold Coast from 19–23 October 2026. The 2026 Australia–China BioInnovation Roundtable is proud to be an official satellite event partner.
Australia's Biggest Week in Biotech →